Invitation to presentation of Nanoform's year-end report for 2020 on February 26, 2021
Nanoform is an innovative nanoparticle medicine enabling company.
- Nanoform is an innovative nanoparticle medicine enabling company.
- Nanoform's shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS).
- Certified Adviser: Danske Bank A/S, Finland Branch,+358 40 562 1806.
- For more information please visit http://www.nanoform.com